$FTXP submitted its OTCIQ Order Form to subscribe to the
$FTXP submitted its OTCIQ Order Form to subscribe to the OTC Disclosure & News Service. This marks an important step for the Company towards becoming current on the OTC Pink Sheets and ultimately management’s intended upgrade back to the OTCQB.
The Company is focused on becoming compliant and upgrading to the Pink Sheet Current tier on the OTC markets reporting under the Alternative Reporting Standard Guidelines. This is the first in a series of steps the Company is undertaking towards ultimately upgrading its listing back onto the OTCQB. Once the Company obtains OTC Markets’ anticipated approval, it intends to begin filing its financial statements in sequential order as each is completed and expects to perform all necessary filings to become “current” within the next 60 days.
Once the Company is current with its required filings and disclosures, it expects to aggressively pursue several business opportunities that will enhance its business model in 2021, while continuing to build itself as an oil and gas exploration company focused on the transformation of energy to low-carbon energy sources.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Beyond Backpacks: Essential Hygiene for Hartford Kids When September rolls around, it’s not just about those shiny new backpacks and unopened notebooks. In good ol’ Hartford, some students find themselves in need of basics that get overlooked—a stick of deodorant, a bar of soap, maybe some period products. Skimp on these, and all of a sudden, showing up for school...
Continue Reading
Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...
Continue Reading
GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...
Continue Reading
What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...
Continue Reading
A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...
Continue Reading
Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...
Continue Reading
Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...
Continue Reading
A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...
Continue Reading
Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...
Continue Reading
Unraveling the Gray Wolf Controversy What are we looking at here—political maneuvering wrapped in a fur coat? Trump's executive order is making some calls I didn’t see coming. By pushing to delist the gray wolf from the Endangered Species Act (ESA), he's stirring up a mix of joy, outrage, and a boatload of debate about environmental ethics, conservation priorities,...
Continue Reading
Top 5 Most Recently Viewed Articles
CLOU Launches Aqua-E261 & Aqua-X261 Energy Storage Systems CLOU Electronics has made a significant mark in the energy sector by introducing its next-generation commercial and industrial (C&I) liquid-cooled energy storage systems, the Aqua-E261 and Aqua-X261, at a prominent solar energy expo. This reveals the company’s dedication to providing cutting-edge energy...
Continue Reading
Upcoming Earnings for Lands' End: Insights and Expectations Lands' End (NASDAQ: LE) is on the cusp of releasing its latest quarterly earnings report. With anticipation brewing among investors, crucial insights into the company's financial health and future guidance are coming to light. Earnings Estimates and Market Reactions Analysts project that Lands' End may announce...
Continue Reading
Phagenesis Welcomes Chad Hoskins as CEO Phagenesis, a pioneering company in the field of neurostimulation therapies, has announced a major leadership transition with the appointment of Chad Hoskins as Chief Executive Officer. This change comes on the heels of the company’s recent successes, including securing $42 million in Series D funding aimed at expanding the reach...
Continue Reading
Class Action Lawsuit Against ASP Isotopes Inc. Recently, Robbins LLP has informed investors about a class action that was filed against ASP Isotopes Inc. (NASDAQ: ASPI). This lawsuit involves individuals and entities who purchased or acquired securities related to ASP Isotopes during a specified period. The company is currently recognized as a development-stage firm that...
Continue Reading
Exciting Partnership in Disinfection Solutions TOMI Environmental Solutions, Inc.® (NASDAQ: TOMZ), a leader in disinfection technologies, recently announced a significant OEM partnership with Pharma Biotech System Components LLC. This collaboration is set to elevate the effectiveness of TOMI's SteraMist Integrated System (SIS) through the integration of innovative...
Continue Reading